Related Experiment Videos
[Huntington's chorea: clinical aspects, genetics and current diagnosis]
1Institut für Medizinische Genetik, Universität Zürich.
Therapeutische Umschau. Revue Therapeutique
|December 1, 1995
Summary
Huntington's disease is a neurodegenerative disorder caused by an expanded CAG trinucleotide repeat in the Huntington gene. Genetic testing can identify at-risk individuals and offers insights into disease onset and progression.
Area of Science:
- Neurogenetics
- Molecular Biology
Context:
- Huntington's disease is a late-onset, autosomal dominant neurodegenerative disorder.
- Characterized by motor, cognitive, and psychiatric symptoms.
- The genetic mutation involves an unstable trinucleotide [CAG] repeat expansion in the Huntington gene.
Purpose:
- To discuss the identification and implications of the Huntington gene mutation.
- To highlight the role of genetic testing in diagnosis and risk assessment.
- To explore the correlation between CAG repeat size and age of onset.
Summary:
- The mutation is an expanded CAG trinucleotide repeat in the Huntington gene, detectable by standard methods.
- Genetic testing is available for diagnosing questionable cases and screening at-risk individuals.
- A correlation exists between expanded CAG repeat size and age of onset, though predictive value is limited.
- Expanded repeats show instability, particularly in male meiosis, potentially explaining anticipation and juvenile cases.
Impact:
- Accurate genetic testing can now be offered to presymptomatic individuals.
- Understanding repeat instability sheds light on disease anticipation and new mutations.
- Provides a basis for future research into Huntington's disease mechanisms and potential therapies.